As the analysis of anti-RNP70 antibodies has been claimed to have advantages in terms of diagnosing MCTD [15,16,17,18], we evaluated this further using relevant comparators for anti-U1-RNP antibodies that are usually available in routine ANA screening. This evidence concerns the gene RNPC3 and mixed connective tissue disease.